Clinical Catch-Up: January 4-8 | BioSpace
The Pharma Data
JANUARY 10, 2021
The new year began with a fairly low level of clinical trial news. Arcturus Therapeutics got the FDA go-ahead for its Phase II trial of its COVID-19 vaccine candidate ARCT-021. The trial will enroll 600 participants, with 450 receiving ARCT-021 and 150 receiving placebo. Here’s a look. COVID-19-Related.
Let's personalize your content